[1] Riancho, J., Peris, P., González-Macías, J., & Pérez-Castrillón, J.Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis. SEIOMM (Vol. 14). Rev Osteoporos Metab Miner 2022;14:14-33
[2] J.R. Aguilera; P. Garza Ríos; A. Sánchez Zepeda. Calcio y vitamina D en la paciente climatèrica. Calcium and Vitamin D in postmenopausal women. Perinatol Reprod Hum. 2015;29(2):83-87
[3] O'Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJ. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am J Med. 2005 Jul;118(7):778-81
DOI: 10.1016/j.amjmed.2005.02.007
[4] Avenell A, Mak JC, O'Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev. 2014 Apr 14;2014(4):CD000227.
DOI: 10.1002/14651858.CD000227.pub4
[5] J.G. Zhao, X.T. Zeng, J. Wang, L. Liu. Association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults: A systematic review and meta-analysis.JAMA. 2017, 318:2466-82
DOI: 10.1001/jama.2017.19344
[6] Li K, Wang XF et al. The good, the bad, and the ugly of calcium supplementation: a review of calcium intake on human health. Clin Interv Aging. 2018 Nov 28;13:2443-2452.
DOI: 10.2147/CIA.S157523
[7]Taylor EN, Curhan GC. Dietary calcium from dairy and nondairy sources, and risk of symptomatic kidney stones. J Urol. 2013 Oct;190(4):1255-9.
DOI: 10.1016/j.juro.2013.03.074
[8]Wallace RB, Wactawski-Wende J, O'Sullivan MJ, Larson JC, Cochrane B, Gass M, Masaki K. Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr. 2011 Jul;94(1):270-7.
DOI: 10.3945/ajcn.110.003350
[9] Harris SS, Dawson-Hughes B. Effects of Hydration and Calcium Supplementation on Urine Calcium Concentration in Healthy Postmenopausal Women. J Am Coll Nutr. 2015;34(4):340-6.
DOI: 10.1080/07315724.2014.959207
[10] Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010 Jul 29;341:c3691.
DOI: 10.1136/bmj.c3691
[11]Myung SK, Kim HB, Lee YJ, Choi YJ, Oh SW. Calcium Supplements and Risk of Cardiovascular Disease: A Meta-Analysis of Clinical Trials. Nutrients. 2021 Jan 26;13(2):368.
DOI: 10.3390/nu13020368
[12]Chung M, Tang AM, Fu Z, Wang DD, Newberry SJ. Calcium Intake and Cardiovascular Disease Risk: An Updated Systematic Review and Meta-analysis. Ann Intern Med. 2016 Dec 20;165(12):856-866.
DOI: 10.7326/M16-1165
[13]Sim MG, Teo YN, Teo YH, Syn NL, Li TYW, Yeo LLL, Kong WKF, Tan BYQ, Yip JW, Wong RCC, Poh KK, Yeo TC, Sharma VK, Chai P, Chan MY, Sia CH. Association Between Calcium Supplementation and the Risk of Cardiovascular Disease and Stroke: A Systematic Review and Meta-Analysis. Heart Lung Circ. 2023 Oct;32(10):1230-1239.
DOI: 10.1016/j.hlc.2023.07.008
[14] Cano A, Chedraui P, Goulis DG, Lopes P, Mishra G, Mueck A, Senturk LM, Simoncini T, Stevenson JC, Stute P, Tuomikoski P, Rees M, Lambrinoudaki I. Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide. Maturitas. 2018 Jan;107:7-12.
DOI: 10.1016/j.maturitas.2017.10.004
[15] Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R; National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014 Oct;25(10):2359-81.
DOI: 10.1007/s00198-014-2794-2
[16]. Olza J, Aranceta-Bartrina J, González-Gross M, Ortega RM, Serra-Majem L, Varela-Moreiras G, et al. reported dietary intake, disparity between the reported consumption and the level needed for adequacy and food sources of calcium, phosphorus, magnesium and vitamin d in the Spanish population: findings from the ANIBES Study. Nutrients. 2017;9(2):232
[17] Serra-Majem L, Ribas-Barba L, Salvador G, Jover L, Raidó B, Ngo J, Plasencia A. Trends in energy and nutrient intake and risk of inadequate intakes in Catalonia, Spain (1992-2003). Public Health Nutr. 2007 Nov;10(11A):1354-67.
DOI: 10.1017/S1368980007000961
[18] Arriaza E, M.C. Arévalo; MA Grandas; J Rebollo; T Olleros. Consumo de calcio por la mujer española de entre 45 y 65 años. Calcium intake in Spanish women aged between 45 and 65 years old. Prog Obstet Ginecol. 2005;48(7):338-44
DOI: 10.1016/S0304-5013(05)72408-0
[19] Fan T, Nocea G, Modi A, Stokes L, Sen SS. Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study. Clin Interv Aging. 2013;8:689-96.
[20] Bruyère O, Malaise O, Neuprez A, Collette J, Reginster JY. Prevalence of vitamin D inadequacy in European postmenopausal women. Current Medical Research and Opinion. 2007 Aug;23(8):1939-1944
DOI: 10.1185/030079907X219562
[21] Salas-Salvadó, Jordi, Babio, Nancy, Juárez-Iglesias, Manuela, Picó, Catalina, Ros, Emilio, & Moreno Aznar, Luís A. (2018). Importancia de los alimentos lácteos en la salud cardiovascular:¿enteros o desnatados?. Nutrición Hospitalaria, 35(6), 1479-90
[22]. Ortega-Anta, Rosa María et al . Ingesta de calcio y vitamina D en una muestra representativa de mujeres españolas: problemática específica en menopausia. Calcium and vitamin D intakes in a representative sample of spanish women; particular problem in menopause. Nutr. Hosp.2013;28(2):306-313
[23] Huertas JR, Rodríguez Lara A, González Acevedo O, Mesa-García MD. Leche y productos lácteos como vehículos de calcio y vitamina D: papel de las leches enriquecidas [Milk and dairy products as vehicle for calcium and vitamin D: role of calcium enriched milks]. Nutr Hosp. 2019 Aug 26;36(4):962-73.
[24].Sanfelix-Genovés J, Gil-Guillén VF, Orozco-Beltran D, Giner-Ruiz V, Pertusa-Martínez S, Reig-Moya B, Carratalá C. Determinant factors of osteoporosis patients' reported therapeutic adherence to calcium and/or vitamin D supplements: a cross-sectional, observational study of postmenopausal women. Drugs Aging. 2009;26(10):861-69.
[25] Imaz I, Zegarra P, González-Enríquez J, Rubio B, Alcazar R, Amate JM. Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int. 2010 Nov;21(11):1943-51.
DOI: 10.1007/s00198-009-1134-4
[26] Carbonell Abella C, Guañabens Gay N, Regadera Anechina L, Marín Rives JA, Taverna Llauradó E, Ayechu Redín MP; ADHEPOR. Análisis del cumplimiento terapéutico en mujeres con osteoporosis [Analysis of therapeutic compliance in women with osteoporosis]. Reumatol Clin. 2011 Sep-Oct;7(5):299-304.
DOI: 10.1016/j.reuma.2010.12.003
[27] Yeam CT, Chia S, Tan HCC, Kwan YH, Fong W, Seng JJB. A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int. 2018 Dec;29(12):2623-2637.
DOI: 10.1007/s00198-018-4759-3
[28] Alyousif Z, Ford AL, Dahl WJ. Calcium Supplementation Does Not Contribute to Constipation in Healthy Women. Can J Diet Pract Res. 2016 Jun;77(2):103-05.
DOI: 10.3148/cjdpr-2015-043
[29] Zhang X, Wang Z, Zhang D, Ye D, Zhou Y, Qin J, Zhang Y. The prevalence and treatment rate trends of osteoporosis in postmenopausal women. PLoS One. 2023 Sep 26;18(9):e0290289.
DOI: 10.1371/journal.pone.0290289
[30] Langdahl B. Treatment of postmenopausal osteoporosis with bone-forming and antiresorptive treatments: Combined and sequential approaches. Bone. 2020 Oct;139:115516.
DOI: 10.1016/j.bone.2020.115516
[32] Pineda-Moncusí M, Garcia-Giralt N, Diez-Perez A, et al. Increased Fracture Risk in Women Treated With Aromatase Inhibitors Versus Tamoxifen: Beneficial Effect of Bisphosphonates. Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research. 2020 Feb;35(2):291-297.
DOI: 10.1002/jbmr.3886